Isradipine plasma pharmacokinetics and exposure–response in early Parkinson’s disease

by Charles S. Venuto, Luoying Yang, Monica Javidnia, David Oakes, D. James Surmeier, Tanya Simuni
Published 2021-03-01

Phenotype–genotype discrepancies in the prospective Huntington at‐risk observational study

by Ira Shoulson, Shirley Eberly, David Oakes, Elise Kayson, Anne B. Young, the PHAROS Investigators
Published 2019-06-01

Serum cholesterol and the progression of Parkinson's disease: results from DATATOP.

by Xuemei Huang, Peggy Auinger, Shirley Eberly, David Oakes, Michael Schwarzschild, Alberto Ascherio, Richard Mailman, Honglei Chen, Parkinson Study Group DATATOP Investigators
Published 2011-01-01

Design of a virtual longitudinal observational study in Parkinson’s disease (AT‐HOME PD)

by Ruth B. Schneider, Larsson Omberg, Eric A. Macklin, Margaret Daeschler, Lauren Bataille, Shalini Anthwal, Taylor L. Myers, Elizabeth Baloga, Sidney Duquette, Phil Snyder, Katherine Amodeo, Christopher G Tarolli, Jamie L. Adams, Katherine F Callahan, Joshua Gottesman, Catherine M. Kopil, Codrin Lungu, Alberto Ascherio, James C. Beck, Kevin Biglan, Alberto J. Espay, Caroline Tanner, David Oakes, Ira Shoulson, Dan Novak, Elise Kayson, Earl Ray Dorsey, Lara Mangravite, Michael A. Schwarzschild, Tanya Simuni, the Parkinson Study Group AT‐HOME PD Investigators
Published 2021-02-01